Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes.
Identifying the targets of broadly neutralizing antibodies to HIV-1 and understanding how these antibodies develop remain important goals in the quest to rationally develop an HIV-1 vaccine. We previously identified a participant in the CAPRISA Acute Infection Cohort (CAP257) whose plasma neutralize...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-10-01
|
| Series: | PLoS Pathogens |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24204277/pdf/?tool=EBI |
| _version_ | 1828940228235100160 |
|---|---|
| author | Constantinos Kurt Wibmer Jinal N Bhiman Elin S Gray Nancy Tumba Salim S Abdool Karim Carolyn Williamson Lynn Morris Penny L Moore |
| author_facet | Constantinos Kurt Wibmer Jinal N Bhiman Elin S Gray Nancy Tumba Salim S Abdool Karim Carolyn Williamson Lynn Morris Penny L Moore |
| author_sort | Constantinos Kurt Wibmer |
| collection | DOAJ |
| description | Identifying the targets of broadly neutralizing antibodies to HIV-1 and understanding how these antibodies develop remain important goals in the quest to rationally develop an HIV-1 vaccine. We previously identified a participant in the CAPRISA Acute Infection Cohort (CAP257) whose plasma neutralized 84% of heterologous viruses. In this study we showed that breadth in CAP257 was largely due to the sequential, transient appearance of three distinct broadly neutralizing antibody specificities spanning the first 4.5 years of infection. The first specificity targeted an epitope in the V2 region of gp120 that was also recognized by strain-specific antibodies 7 weeks earlier. Specificity for the autologous virus was determined largely by a rare N167 antigenic variant of V2, with viral escape to the more common D167 immunotype coinciding with the development of the first wave of broadly neutralizing antibodies. Escape from these broadly neutralizing V2 antibodies through deletion of the glycan at N160 was associated with exposure of an epitope in the CD4 binding site that became the target for a second wave of broadly neutralizing antibodies. Neutralization by these CD4 binding site antibodies was almost entirely dependent on the glycan at position N276. Early viral escape mutations in the CD4 binding site drove an increase in wave two neutralization breadth, as this second wave of heterologous neutralization matured to recognize multiple immunotypes within this site. The third wave targeted a quaternary epitope that did not overlap any of the four known sites of vulnerability on the HIV-1 envelope and remains undefined. Altogether this study showed that the human immune system is capable of generating multiple broadly neutralizing antibodies in response to a constantly evolving viral population that exposes new targets as a consequence of escape from earlier neutralizing antibodies. |
| first_indexed | 2024-12-14T03:14:42Z |
| format | Article |
| id | doaj.art-0c857a556c964276b43d258fe5d7a14d |
| institution | Directory Open Access Journal |
| issn | 1553-7366 1553-7374 |
| language | English |
| last_indexed | 2024-12-14T03:14:42Z |
| publishDate | 2013-10-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Pathogens |
| spelling | doaj.art-0c857a556c964276b43d258fe5d7a14d2022-12-21T23:19:10ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742013-10-01910e100373810.1371/journal.ppat.1003738Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes.Constantinos Kurt WibmerJinal N BhimanElin S GrayNancy TumbaSalim S Abdool KarimCarolyn WilliamsonLynn MorrisPenny L MooreIdentifying the targets of broadly neutralizing antibodies to HIV-1 and understanding how these antibodies develop remain important goals in the quest to rationally develop an HIV-1 vaccine. We previously identified a participant in the CAPRISA Acute Infection Cohort (CAP257) whose plasma neutralized 84% of heterologous viruses. In this study we showed that breadth in CAP257 was largely due to the sequential, transient appearance of three distinct broadly neutralizing antibody specificities spanning the first 4.5 years of infection. The first specificity targeted an epitope in the V2 region of gp120 that was also recognized by strain-specific antibodies 7 weeks earlier. Specificity for the autologous virus was determined largely by a rare N167 antigenic variant of V2, with viral escape to the more common D167 immunotype coinciding with the development of the first wave of broadly neutralizing antibodies. Escape from these broadly neutralizing V2 antibodies through deletion of the glycan at N160 was associated with exposure of an epitope in the CD4 binding site that became the target for a second wave of broadly neutralizing antibodies. Neutralization by these CD4 binding site antibodies was almost entirely dependent on the glycan at position N276. Early viral escape mutations in the CD4 binding site drove an increase in wave two neutralization breadth, as this second wave of heterologous neutralization matured to recognize multiple immunotypes within this site. The third wave targeted a quaternary epitope that did not overlap any of the four known sites of vulnerability on the HIV-1 envelope and remains undefined. Altogether this study showed that the human immune system is capable of generating multiple broadly neutralizing antibodies in response to a constantly evolving viral population that exposes new targets as a consequence of escape from earlier neutralizing antibodies.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24204277/pdf/?tool=EBI |
| spellingShingle | Constantinos Kurt Wibmer Jinal N Bhiman Elin S Gray Nancy Tumba Salim S Abdool Karim Carolyn Williamson Lynn Morris Penny L Moore Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes. PLoS Pathogens |
| title | Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes. |
| title_full | Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes. |
| title_fullStr | Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes. |
| title_full_unstemmed | Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes. |
| title_short | Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes. |
| title_sort | viral escape from hiv 1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24204277/pdf/?tool=EBI |
| work_keys_str_mv | AT constantinoskurtwibmer viralescapefromhiv1neutralizingantibodiesdrivesincreasedplasmaneutralizationbreadththroughsequentialrecognitionofmultipleepitopesandimmunotypes AT jinalnbhiman viralescapefromhiv1neutralizingantibodiesdrivesincreasedplasmaneutralizationbreadththroughsequentialrecognitionofmultipleepitopesandimmunotypes AT elinsgray viralescapefromhiv1neutralizingantibodiesdrivesincreasedplasmaneutralizationbreadththroughsequentialrecognitionofmultipleepitopesandimmunotypes AT nancytumba viralescapefromhiv1neutralizingantibodiesdrivesincreasedplasmaneutralizationbreadththroughsequentialrecognitionofmultipleepitopesandimmunotypes AT salimsabdoolkarim viralescapefromhiv1neutralizingantibodiesdrivesincreasedplasmaneutralizationbreadththroughsequentialrecognitionofmultipleepitopesandimmunotypes AT carolynwilliamson viralescapefromhiv1neutralizingantibodiesdrivesincreasedplasmaneutralizationbreadththroughsequentialrecognitionofmultipleepitopesandimmunotypes AT lynnmorris viralescapefromhiv1neutralizingantibodiesdrivesincreasedplasmaneutralizationbreadththroughsequentialrecognitionofmultipleepitopesandimmunotypes AT pennylmoore viralescapefromhiv1neutralizingantibodiesdrivesincreasedplasmaneutralizationbreadththroughsequentialrecognitionofmultipleepitopesandimmunotypes |